IP Library Granted Patent US 6,855,502
Granted Patent B2
US 6,855,502 · App. 10/124,222 · Granted Feb 15, 2005

Hyaluronate synthase gene and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,855,502
App. No.
10/124,222
Granted
Feb 15, 2005
Kind
B2
Abstract

Disclosed are DNA sequences encoding hyaluronic acid synthase that are employed to construct recombinant cells useful in the production of hyaluronate synthase and hyaluronic acid (HA). In preferred aspects, chromosomal DNA encoding the HA synthase gene, hasA, was cloned from a Streptococcus pyogenes genomic library. These vectors were used to transform host cells such as E. coli and acapsular Streptococci to produce hyaluronic acid. Resultant transformants were screened to identify colonies which have incorporated HA synthase DNA in a form that is being actively transcribed into the corresponding HA synthase enzyme. These colonies were selected and employed in the production of hyaluronic acid.

Claims (12)

1. A method of detecting a DNA species comprising the steps of:

(a) obtaining a DNA sample;

(b) contacting said DNA sample with a nucleic acid segment in accordance with SEQ ID NO:1 under conditions effective to allow hybridization to form a complex; and

(c) detecting said complex.

2. A method for detecting a bacterial cell that expresses hyaluronic acid synthase, comprising the steps of:

(a) obtaining a bacterial cell sample suspected of expressing hyaluronan synthase;

(b) contacting nucleic acids from said cell sample with a nucleic acid segment in accordance with SEQ ID NO:1 under conditions effective to allow hybridization of substantially complementary nucleic acid sequences; and

(c) identifying the presence of hybridized complexes containing substantially complementary nucleic acid sequences within said sample; wherein the presence of increased levels of said substantially complementary nucleic acid sequence is indicative of a bacterial strain that expresses hyaluronan synthase.

3. The method of claim 1 , wherein the nucleic acids contacted are located within said cell.

4. The method of claim 1 , wherein the nucleic acids are separated from said cell prior to contact.

5. The method of claim 1 , wherein the nucleic acid segment comprises a detectable label and hybridized complexes are detected by detecting said label.

6. The method of claim 2 , wherein said nucleic acid segment comprises a radio-, an enzymatic-, a fluorescent-, a biotinyl-, or a chemiluminescent-label.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 14, 2010
From: UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024973/0721 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jul 17, 2008
From: UNIVERSITY OF OKLAHOMA HLTH SCIENCES CT
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021250/0112 →
Continuity (3)
Continuation 0914689300 · Sep 3, 1998
Continuation 0827058100 · Jul 1, 1994
Related Publication 20030104415A1 · Jun 5, 2003